VIA
XBI icon

Vantage Investment Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Vantage Investment Advisors’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-100
Closed -$9K – 833
2018
Q1 		$9K Hold
100
– – ﹤0.01% 587
2017
Q4 		$8K Hold
100
– – ﹤0.01% 622
2017
Q3 		$9K Hold
100
– – ﹤0.01% 589
2017
Q2 		$8K Hold
100
– – ﹤0.01% 593
2017
Q1 		$7K Hold
100
– – ﹤0.01% 597
2016
Q4 		$6K Hold
100
– – ﹤0.01% 606
2016
Q3 		$7K Hold
100
– – ﹤0.01% 569
2016
Q2 		$5K Buy
+100
New +$5.48K ﹤0.01% 628

Other funds holding XBI

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $157B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $152B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return